Akebia Therapeutics (AKBA) Treasury Shares (2013 - 2025)

Akebia Therapeutics (AKBA) has 3 years of Treasury Shares data on file, last reported at $162000.0 in Q1 2016.

• Treasury Shares for Q1 2016 came in at $162000.0, up 0.62% year-over-year; the trailing twelve-month figure through Mar 2016 was $162000.0 (up 0.62% YoY), and the FY2015 annual result was $162000.0, changed 0.0% from the prior year.
• Treasury Shares steadied at $162000.0 in Q1 2016 per AKBA's latest filing, from $162000.0 in the prior quarter.
• Over five years, Treasury Shares peaked at $6.4 million in Q2 2025 and troughed at $99558.0 in Q4 2021.
• A 4-year average of $2.5 million and a median of $1.7 million in 2024 frame the typical range for Treasury Shares.
• On a YoY basis, Treasury Shares climbed as much as 658.36% in 2015 and fell as far as 0.0% in 2015.
• A 3-year view of Treasury Shares shows it stood at $162000.0 in 2014, then changed by 0.0% to $162000.0 in 2015, then changed by 0.0% to $162000.0 in 2016.
• Business Quant data shows AKBA's Treasury Shares at $162000.0 in Q1 2016, $162000.0 in Q4 2015, and $162000.0 in Q3 2015.